Cargando…

Feasibility of Discontinuing Biologics in Severe Asthma: An Algorithmic Approach

In severe asthma with type 2 (T2) inflammation, biologics targeting key mediators of T2 inflammation, including interleukin (IL)-5, IL-4/IL-13, and immunoglobulin (Ig)E, remarkably improve the management of severe asthma, providing new insights into the clinical course of asthma such as disease modi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamada, Kazuki, Oishi, Keiji, Murata, Yoriyuki, Hirano, Tsunahiko, Matsunaga, Kazuto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665775/ https://www.ncbi.nlm.nih.gov/pubmed/34908847 http://dx.doi.org/10.2147/JAA.S340684

Ejemplares similares

A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma
por: Oishi, Keiji, et al.
Publicado: (2023)

Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart
por: Oishi, Keiji, et al.
Publicado: (2023)

Computed Tomography Lung Density Analysis: An Imaging Biomarker Predicting Physical Inactivity in Chronic Obstructive Pulmonary Disease: A Pilot Study
por: Murata, Yoriyuki, et al.
Publicado: (2023)

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media
por: Chikumoto, Ayumi, et al.
Publicado: (2022)

Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study
por: Oishi, Keiji, et al.
Publicado: (2019)

Three‐step algorithm for biological therapy targeted IgE and IL‐5 in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2018)

Late-onset asthma: current perspectives
por: Hirano, Tsunahiko, et al.
Publicado: (2018)

A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2017)

Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease
por: Hirano, Tsunahiko, et al.
Publicado: (2022)

Utility of the Shortness of Breath in Daily Activities Questionnaire (SOBDA-Q) to Detect Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Yamaji, Yoshikazu, et al.
Publicado: (2023)

Non‐pneumophila Legionella species pneumonia with orange‐coloured sputum
por: Asami‐Noyama, Maki, et al.
Publicado: (2021)

Neural Network Approach to Investigating the Importance of Test Items for Predicting Physical Activity in Chronic Obstructive Pulmonary Disease
por: Nakahara, Yoshiki, et al.
Publicado: (2023)

Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
por: Matsunaga, Kazuto, et al.
Publicado: (2020)

A New Dyspnea Evaluation System Focusing on Patients’ Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty
por: Oishi, Keiji, et al.
Publicado: (2020)

Impact of Frailty on Hippocampal Volume in Patients with Chronic Obstructive Pulmonary Disease
por: Takahashi, Shun, et al.
Publicado: (2021)

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan
por: Oishi, Keiji, et al.
Publicado: (2018)

Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs
por: Ohteru, Yuichi, et al.
Publicado: (2022)

Deep Sternal Wound Tuberculosis with Hypo-gamma-globulinemia
por: Hamada, Kazuki, et al.
Publicado: (2018)

Cryptococcosis as a cause of organizing pneumonia
por: Chikumoto, Ayumi, et al.
Publicado: (2019)

False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice Aspiration
por: Yamamoto, Tasuku, et al.
Publicado: (2022)

A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPD
por: Hirano, Tsunahiko, et al.
Publicado: (2020)

A case of development of autoimmune pulmonary alveolar proteinosis during the treatment of hypersensitivity pneumonitis
por: Asami-Noyama, Maki, et al.
Publicado: (2023)

Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan
por: Kakugawa, Tomoyuki, et al.
Publicado: (2023)

Platypnea‐orthodeoxia syndrome in a patient with ongoing COVID‐19
por: Asami‐Noyama, Maki, et al.
Publicado: (2022)

Time To Revise COPD Treatment Algorithm
por: Matsunaga, Kazuto, et al.
Publicado: (2019)

Author Correction: The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease
por: Oishi, Keiji, et al.
Publicado: (2022)

The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease
por: Oishi, Keiji, et al.
Publicado: (2022)

Orthogonality-Constrained CNMF-Based Noise Reduction with Reduced Degradation of Biological Sound
por: Murakami, Naoto, et al.
Publicado: (2021)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
por: Oishi, Keiji, et al.
Publicado: (2020)

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
por: Akamatsu, Keiichiro, et al.
Publicado: (2011)

Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma
por: Kawazoe, Yusuke, et al.
Publicado: (2023)

Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease
por: Minakata, Yoshiaki, et al.
Publicado: (2015)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Biological treatments for severe asthma
por: Jin, Hyun Jung
Publicado: (2020)

Biologic Therapy and Severe Asthma in Children
por: Russo, Daniele, et al.
Publicado: (2021)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis
por: Oishi, Keiji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qcdj2k3onl56iv9c8fqbq7f9st